Eli Lilly CEO Says Industry Needs Pricing Innovation

Jan.09 -- David Ricks, chairman and chief executive officer at Eli Lilly & Co., discusses drug pricing and shifting industry dynamics. He speaks with Erik Schatzker on "Bloomberg Markets" from the JPMorgan Health Care Conference in San Francisco.

(Source: Bloomberg TV - Markets and Finance, January 9, 2018 at 11:41AM)

Recommended posts powered by Google